FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On November 1, 2005
Table of Contents
Docket # Title
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
1999P-0033 Combat the spread of transmissible spongiform encephalopathy
1999P-1340 Declared Eternity eau de Parfum Misbranded
2000P-1491 Amend Definition & Standard of Identy for Parmesan Cheese
2001P-0345 Listing the color additive yellow #5 for use in food/Drug
2002D-0325 Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
2002N-0273 Animal Proteins Prohibited in Ruminant Feed
2002P-0317 Recall Aspartame as a Neurotoxic Drug
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
2003P-0132 Part 135 FDA regulations standard of identity frozen dessert
2004H-0322 Civil Money Penalty Re: Ecumed Health Group, Inc.
2005D-0261 Guidance for Industry: Nucleic Acid Testing (NAT) for Human Immunodeficiency Virus Type 1 (HIV-1) and Hepatitis C Virus (HCV): Testing, Product Disposition, and Donor Deferral and Reentry
2005D-0385 Guidance for Industry on Using Electronic Means to Distribute Certain Product Information
2005D-0412 Guidance for Industry: A Notice from the Food and Drug Administration to Growers, Food Manufacturers, Food Warehouse Managers, and Transporters of Food Products on Decontamination of Transport Vehicle
2005M-0435 P960040/S028 - VENTAK PRIZM AVT System, Approved 3/27/03
2005N-0311 Critical Path Initiative; Developing Prevention Therapies; Planning of Workshop
2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
2005N-0354 Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
2005N-0404 Solicitation of Public Review and Comment on Research Protocol:
2005N-0426 Agency Information Collection Activities; Proposed Collection; Comment Request; Notice of Participation
2005P-0267 Remove from label for propofol (Diprivan) the warning that propofol should be administered only by trained persons
2005P-0323 Immediately remove Adderall and Adderall XR from the market for safety reasons
2005P-0436 ADA 21-863' Ibuprogen Liquid filled gelatin capsules 200 mg; Ranbaxy Laboratories, Ltd.
2005P-0440 To deny approval of Smith & Nephew's premarket approval application (PMA) for the Birmingham hip resurfacing system (P040033) based on the data currently submitted in support of the PMA
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 16709 DMD Pharmaceuticals Vol #: 150
LET 16710 WTSmed Vol #: 150
LET 16711 Mediainfo Vol #: 150
LET 16712 ProCaps Laboratories Vol #: 150
LET 16713 Nutramax Laboratories, Inc. Vol #: 150
LET 16714 Herbalist Alchemist Vol #: 150
LET 16715 Cadbury Adams USA LLC Vol #: 150
LET 16716 Caudill Seed Company Vol #: 150
LET 16717 Nature's Way Products, Inc. Vol #: 150
LET 16718 FoodScience Corporation Vol #: 150
LET 16719 Childlife Nutrition for Kids! Vol #: 150
LET 16720 Childlife Nutrition for Kids! Vol #: 150
LET 16721 Now Foods Vol #: 150
LET 16722 Univera, Inc.,d.b.a Oasis LifeSciences Vol #: 150
LET 16723 Pharmavite LLC Vol #: 150
LET 16724 Pharmavite LLC Vol #: 150
LET 16725 EX3 Energy Vol #: 150
LET 16726 Pharmavite LLC Vol #: 150
LET 16727 Pharmavite LLC Vol #: 150
LET 16728 Pharmavite LLC Vol #: 150
LET 16729 Pharmavite LLC Vol #: 150
LET 16730 Pharmavite LLC Vol #: 150
1999P-0033 Combat the spread of transmissible spongiform encephalopathy
EMC 7 A. Stapleton Vol #: 9
EMC 8 K. Borek Vol #: 9
EMC 9 B. Freese Vol #: 9
EMC 10 D. Wichar Vol #: 9
EMC 11 F. Jakobcic Vol #: 9
EMC 12 S. Wellman Vol #: 9
EMC 13 K. Lipiatos Vol #: 9
1999P-1340 Declared Eternity eau de Parfum Misbranded
EMC 613 S. Bondi Vol #: 24
EMC 614 E. Reid Vol #: 24
EMC 615 D. Dudish Vol #: 24
2000P-1491 Amend Definition & Standard of Identy for Parmesan Cheese
EMC 2 J. Deni, II Vol #: 1
2001P-0345 Listing the color additive yellow #5 for use in food/Drug
EMC 1293 M. Miracle Vol #: 6
EMC 1294 S. Gruber Vol #: 6
2002D-0325 Polyvinychloride using Plasticier di-(2-ethyhexyl)phthalate
EMC 231 M. Marler Vol #: 4
EMC 232 M. Wilson Vol #: 4
2002N-0273 Animal Proteins Prohibited in Ruminant Feed
EC 35 Mrs. Carla Yelkovan Vol #: 4
EMC 59 L. Aaron Vol #: 14
EMC 60 J. Cooley Vol #: 14
EMC 61 J. Turk Vol #: 14
EMC 62 L. Henri Vol #: 14
EMC 63 J. Spruce Vol #: 14
EMC 64 C. Getz Vol #: 14
EMC 65 J. Tatum Jr. Vol #: 14
EMC 66 M. Uze Vol #: 14
EMC 67 K. Sgamma Vol #: 14
EMC 68 C. Mizerany Vol #: 14
EMC 69 C. Fisch Vol #: 14
EMC 70 W. Ballentine Vol #: 14
EMC 71 V. Engle Vol #: 14
EMC 72 S. Brahmbhatt Vol #: 14
EMC 73 L. Friedman Vol #: 14
EMC 74 D. Shively Vol #: 14
EMC 75 A. Egbert Vol #: 14
EMC 76 C. Clark Vol #: 14
EMC 77 J. Ballard Vol #: 14
EMC 78 M. Smith Vol #: 14
EMC 79 J. Ballard Vol #: 14
EMC 80 J. Ertel Vol #: 14
EMC 81 K. Miller Vol #: 14
EMC 82 M. Budd Vol #: 14
EMC 83 D. Blanken Vol #: 14
EMC 84 D. Isaacson Vol #: 14
EMC 85 G. Camhi Vol #: 14
EMC 86 H. Gordon Vol #: 14
EMC 87 S. Harrison Vol #: 14
EMC 88 S. Stout Vol #: 14
EMC 89 S. Dobbelaere Vol #: 14
EMC 90 K. Althiser Vol #: 14
EMC 91 B. Atkinson Vol #: 14
EMC 92 L. Lambeth Vol #: 14
EMC 93 J. Wyrick Vol #: 14
EMC 94 R. Herbin Vol #: 14
EMC 95 J. Armstrong Vol #: 14
EMC 96 E. Walsingham Vol #: 14
EMC 97 C. SMith Vol #: 14
EMC 98 H. Cohen Vol #: 14
EMC 99 B. Jones Vol #: 14
EMC 100 P. Herron Vol #: 14
EMC 101 C. Dronzkowski Vol #: 14
EMC 102 W. Brown Vol #: 14
EMC 103 C. Wedding Vol #: 14
EMC 104 N. Wedding Vol #: 14
EMC 105 T. O'Neil Vol #: 14
EMC 106 W. Davis Vol #: 14
EMC 107 R. Tolleson Vol #: 14
EMC 108 B. Fitzpatrick Vol #: 14
EMC 109 B. Flowers Vol #: 14
EMC 110 K. Pence Vol #: 14
EMC 111 C. Frechette Vol #: 14
EMC 112 T. Schram Vol #: 14
EMC 113 S. Hall Vol #: 14
EMC 114 H and M Wood Vol #: 14
EMC 115 E. Honey Vol #: 14
EMC 116 L. Pike Vol #: 14
EMC 117 P. DesChene Vol #: 14
2002P-0317 Recall Aspartame as a Neurotoxic Drug
EMC 546 Mission Possible International Vol #: 8
EMC 547 Mission Possible International Vol #: 8
EMC 548 Calorie Control Council Vol #: 8
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
EMC 1147 J. Olivo Vol #: 11
EMC 1148 J. Hubbard Vol #: 11
EMC 1149 L. Jacobs Vol #: 11
EMC 1150 K. Bryan Vol #: 11
2003P-0132 Part 135 FDA regulations standard of identity frozen dessert
EMC 2 J. Deni, II Vol #: 1
2004H-0322 Civil Money Penalty Re: Ecumed Health Group, Inc.
MO 13 Ecumed Health Group, Amador Reyes, Juan Carrai and Richard Stone, M.D. Vol #: 2
2005D-0261 Guidance for Industry: Nucleic Acid Testing (NAT) for Human Immunodeficiency Virus Type 1 (HIV-1) and Hepatitis C Virus (HCV): Testing, Product Disposition, and Donor Deferral and Reentry
EMC 3
Attachment
Blood Systems, Inc. Vol #: 2
2005D-0385 Guidance for Industry on Using Electronic Means to Distribute Certain Product Information
EC 2 FDAReady Consulting Vol #: 1
2005D-0412 Guidance for Industry: A Notice from the Food and Drug Administration to Growers, Food Manufacturers, Food Warehouse Managers, and Transporters of Food Products on Decontamination of Transport Vehicle
GDL 1 Guidance Vol #: 1
NAD 1 FDA Vol #: 1
2005M-0435 P960040/S028 - VENTAK PRIZM AVT System, Approved 3/27/03
AAV 1 Guidant CRM Corporation Vol #: 1
2005N-0311 Critical Path Initiative; Developing Prevention Therapies; Planning of Workshop
EC 1 American Society of Clinical Oncology Vol #: 1
EC 2 Pfizer Vol #: 1
EC 3 American Society of Clinical Oncology Vol #: 1
EC 4 AstraZeneca Vol #: 1
EC 5 Amer Soc for Clinical Pharmacology & Therapeutics Vol #: 1
2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
EC 2205 Mr. David Benfell Vol #: 32
EMC 217 C. Rubin Vol #: 3
EMC 218 B. Sanders Vol #: 3
EMC 219 A. Hicka Vol #: 3
EMC 220 D. King Vol #: 3
EMC 221 M. Rich Vol #: 4
EMC 222 A. Bruce Vol #: 3
EMC 223 V. Richards Vol #: 3
EMC 224 S. Staley Vol #: 3
EMC 225 No signature Vol #: 3
EMC 226 S. Manewith Vol #: 3
EMC 227 E. Feldman, MD Vol #: 3
EMC 228 L. Howery Vol #: 3
EMC 229 W. Fegenhols Vol #: 3
EMC 230 C. Blum Vol #: 3
EMC 231 S. Sakoutis Vol #: 3
EMC 232 A. Winton Vol #: 3
EMC 233 S. Cohen Vol #: 3
EMC 234 A. Chatterjee Vol #: 3
EMC 235 Q. Lippmann Vol #: 3
EMC 236 R. Hall Vol #: 3
EMC 237 M. Palm, RN Vol #: 3
EMC 238 S. Conklin Vol #: 3
EMC 239 E. Raether Vol #: 3
EMC 240 M. Johnson Vol #: 3
EMC 241 S. Romich Vol #: 3
EMC 242 K. Abrams Vol #: 3
EMC 243 K. Scott Vol #: 3
EMC 244 S. Pfleeger Vol #: 3
EMC 245 M. Corry Vol #: 3
EMC 246 L. Schultz Vol #: 3
EMC 247 N. Sharp Vol #: 3
EMC 248 P. Gianino Vol #: 3
EMC 249 D. Horan Vol #: 3
EMC 250 Planned Parenthood Affiliates of Washington state Vol #: 3
EMC 251 J. Daley Vol #: 3
EMC 252 R. Heuertz Vol #: 3
EMC 253 L. Messner Vol #: 3
EMC 254 A. Gibson Vol #: 3
EMC 255 R. Ray Vol #: 3
EMC 256 L. Sullivan Vol #: 3
EMC 257 F. Ettinger Vol #: 3
EMC 258 M. Fassberg Vol #: 3
EMC 259 M. Lyda Vol #: 3
EMC 260 C. Edquist Vol #: 3
EMC 261 A. Kapner Vol #: 3
EMC 262 M. Abiett Vol #: 3
EMC 263 M. McBride Vol #: 3
EMC 264 K. SMith Vol #: 3
EMC 265 C. Thompson Vol #: 3
EMC 266 R. Miller Vol #: 3
EMC 267 C. McDonnell Vol #: 3
EMC 268 J. Jorgensen Vol #: 3
EMC 269 P. Gutherie Vol #: 3
EMC 270 S. Downes Vol #: 3
EMC 271 J. Stannard Vol #: 3
EMC 272 M. Hannon Vol #: 3
EMC 273 J. Coffey Vol #: 3
EMC 274 J. Glenn Vol #: 3
EMC 275 P. Stancil Vol #: 3
EMC 276 J. Dezsofi Vol #: 3
EMC 277 A. Audette Vol #: 3
EMC 278 E. Voeller Vol #: 3
EMC 279 C. Flanigan Vol #: 3
EMC 280 J. Miner Vol #: 3
EMC 281 J. Richter Vol #: 3
EMC 282 C. Wilke Vol #: 3
EMC 283 L. Falk Vol #: 3
EMC 284 P. Wylie Vol #: 3
EMC 285 A. Stavis Vol #: 3
EMC 286 S. Trejo Vol #: 3
EMC 287 S. Marcus Vol #: 3
EMC 288 A. Tuttle Vol #: 3
EMC 289 R. Youdelman Vol #: 3
EMC 290 L. Quinet Vol #: 4
EMC 291 A. Butts Vol #: 3
EMC 292 Z. Ziemer Vol #: 3
EMC 293 M. Mathias Vol #: 3
EMC 294 J. Mitchell Vol #: 3
EMC 295 F. Farkas Vol #: 3
EMC 296 L. Shrier Vol #: 3
EMC 297 P. King Vol #: 3
EMC 298 A. Lawler Vol #: 3
EMC 299 N. Stephani Vol #: 3
EMC 300 D. Gould Vol #: 3
EMC 301 J. Lewis Vol #: 3
EMC 302 S. Trego Vol #: 3
EMC 303 J. Greene Vol #: 3
EMC 304 K. Haun Vol #: 3
EMC 305 J. Tomczyk Vol #: 3
EMC 306 K. Schoemer Vol #: 3
EMC 307 R. Moyer Vol #: 3
EMC 308 D. Voorhes Vol #: 3
EMC 309 V. Swenson Vol #: 3
EMC 310 S. Needham Vol #: 3
EMC 311 P. Yates Vol #: 3
EMC 312 D. Smatana Vol #: 3
EMC 313 A. Huberman Vol #: 3
EMC 314 L. Martel Vol #: 3
EMC 315 T. Hill Vol #: 3
EMC 316 M. Goodmn Vol #: 3
EMC 317 C. Falnnery Vol #: 3
EMC 318 A. Hansel Vol #: 3
EMC 319 S. McComas Vol #: 3
EMC 320 M. Yacobucci Vol #: 3
EMC 321 J. Hooper Vol #: 3
EMC 322 C. Hemphill Vol #: 3
EMC 323 C. Knapp Vol #: 3
EMC 324 M. Aronson Vol #: 3
EMC 325 S. Lyon Vol #: 3
EMC 326 M. Coronado Vol #: 3
EMC 327 A. Aleman Vol #: 3
EMC 328 C. Johnson Vol #: 3
EMC 329 C. Hunt Vol #: 3
EMC 330 D. Jacobson Vol #: 3
EMC 331 F. Roseberry Vol #: 3
EMC 332 F. Wesley Vol #: 3
EMC 333 L. Pettyjohn Vol #: 3
EMC 334 D. Deagona Vol #: 3
EMC 335 K. McConnell Vol #: 3
EMC 336 S. Barwell Vol #: 3
EMC 337 C. Popcheff Vol #: 3
EMC 338 K. McQuaid Vol #: 3
EMC 339 M. Brophy Vol #: 3
EMC 340 J. Black Vol #: 3
EMC 341 T. Minow Vol #: 3
EMC 342 R. Unger Vol #: 3
EMC 343 J. Blaz Vol #: 3
EMC 344 K. Jordan Vol #: 3
EMC 345 A. Grandov Vol #: 3
EMC 346 S. Clay Vol #: 3
EMC 347 C. Heinecke Vol #: 3
EMC 348 D. Ostenkamp Vol #: 3
EMC 349 R. Chanon Vol #: 3
EMC 350 E. Winter Vol #: 3
EMC 351 H. Shiller Vol #: 3
EMC 352 R. Ruggieri, Jr. Vol #: 3
EMC 353 C. Crocker Vol #: 3
EMC 354 S. Freel Vol #: 3
EMC 355 J. Temple Vol #: 3
EMC 356 S. Stewart Vol #: 3
EMC 357 M. O'Brien Vol #: 3
EMC 358 C. Butlien Vol #: 3
EMC 359 M. Barrett Vol #: 3
EMC 360 M. Ballard Vol #: 3
EMC 361 A, Newcomb Vol #: 3
EMC 362 K. King Vol #: 3
EMC 363 S. Tornheim Vol #: 3
EMC 364 J. Murray Vol #: 3
EMC 365 B. Johnson Vol #: 3
EMC 366 B. Bernard Vol #: 3
EMC 367 S. Zaslaw Vol #: 3
EMC 368 M. Syed Vol #: 3
EMC 369 M. Clark Vol #: 3
EMC 370 L. Franklin Vol #: 3
EMC 371 A. Fusco Vol #: 3
EMC 372 K. Shaw Vol #: 3
EMC 373 P. Tadeo Vol #: 3
EMC 374 S. Thames Vol #: 3
EMC 375 S. Stigleman Vol #: 3
EMC 376 P. Loeff Vol #: 3
EMC 377 A. Roman Vol #: 3
EMC 378 D. Fairbairn Vol #: 3
EMC 379 L. Vest Vol #: 3
EMC 380 A. Green Vol #: 3
EMC 381 G. Robbins Vol #: 3
EMC 382 G. Robbins Vol #: 3
EMC 383 A. Babalola Vol #: 3
EMC 384 M. Dudek Vol #: 3
EMC 385 S. Martinez Vol #: 3
EMC 386 M. McFarland Vol #: 3
EMC 387 E. Cerda Vol #: 3
EMC 388 R. Richardson Vol #: 3
EMC 389 P. Freismuth Vol #: 3
EMC 390 T. Hogle Vol #: 3
EMC 391 T. Bell Vol #: 3
EMC 392 D. Parker Vol #: 3
EMC 393 T. Bell Vol #: 3
EMC 394 F. Dahir Vol #: 3
EMC 395 K. May Vol #: 3
EMC 396 M. Logeland Vol #: 3
EMC 397 T. Vu Vol #: 3
EMC 398 Planned Parenthood Federation of America, Inc. Vol #: 3
EMC 399 S. Carroll Vol #: 3
EMC 400 R. Hall Vol #: 3
EMC 401 American Society for Reproductive Medicine Vol #: 33
EMC 402 J. Grim Vol #: 33
EMC 403 A. Fermoyle Vol #: 33
EMC 404 S. Magee Vol #: 33
EMC 405 C. Spotts Vol #: 33
EMC 406 M. Holston Vol #: 33
EMC 407 S. Morgan Vol #: 33
EMC 408 C. Watloms Vol #: 33
EMC 409 G. Robbins Vol #: 33
EMC 410 W. Wilson Vol #: 33
EMC 411 L. Schiffer Vol #: 33
EMC 412 Honorable Joseph Crowley and Honorable Carolyn B. Maloney Vol #: 33
EMC 413 Honorable Louise M. Slaughter et al. Vol #: 33
EMC 414 The City of New York Vol #: 33
EMC 415 J. James Vol #: 33
EMC 416 S. Prowell Vol #: 33
EMC 417 L. O'Shea Vol #: 33
EMC 418 National Partnership for Women & Families Vol #: 33
2005N-0354 Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
EMC 7 American College of Physicians Vol #: 2
EMC 8 J. Metrock Vol #: 2
EMC 9 No signature Vol #: 2
EMC 10 A. Murray Vol #: 2
EMC 11 K. Anderson Vol #: 2
EMC 12 H. Church Vol #: 2
EMC 13 B. Erickson Vol #: 2
EMC 14 P. Sprague Vol #: 2
EMC 15 J. Paynter Vol #: 14
EMC 16 R. Roast Vol #: 14
EMC 17 J. Fallat Vol #: 2
EMC 18 J. Foster Vol #: 2
EMC 19 M. Sumrall Vol #: 2
EMC 20 S. Young Vol #: 2
EMC 21 J. Sughrue Vol #: 2
EMC 22 P. Fiscella Vol #: 2
EMC 23 W. Wood Vol #: 2
EMC 24 D. Girard Vol #: 2
EMC 25 L. Adler Vol #: 2
EMC 26 E. Gallagher Vol #: 2
EMC 27 D. Schleckser Vol #: 2
EMC 28 B. Deckard Vol #: 2
EMC 29 J. Travis Vol #: 2
EMC 30 B. Wishingrad Vol #: 2
EMC 31 S. Daughtry Vol #: 2
EMC 32 P. Harrell Vol #: 2
EMC 33 B. Massie Vol #: 2
EMC 34 D. O'Connor Vol #: 2
EMC 35 C. Berardo Vol #: 2
EMC 36 J. Whitlow Vol #: 2
EMC 37 C. Roane Vol #: 2
EMC 38 S. Porcaro Vol #: 2
EMC 39 P. Schroeder Vol #: 2
EMC 40 B. Tower Vol #: 2
EMC 41 E. Elgin Vol #: 2
EMC 42 K. Murray Vol #: 2
EMC 43 J and W Davies Vol #: 2
2005N-0404 Solicitation of Public Review and Comment on Research Protocol:
EC 1 Ms. Susan Hayward Vol #: 1
2005N-0426 Agency Information Collection Activities; Proposed Collection; Comment Request; Notice of Participation
N 1 FDA Vol #: 1
2005P-0267 Remove from label for propofol (Diprivan) the warning that propofol should be administered only by trained persons
EC 106 Dr. Dennis Mc Intosh Vol #: 3
EC 107 Mr. Frank Maziarski, CRNA, MS Vol #: 3
EC 108 Dr. William Simpson Vol #: 3
EC 109 SurgiCare of Jacksonville Vol #: 3
EC 110 Hammonton Anesthesia Associates Vol #: 3
EC 111 Dr. Craig Brener Vol #: 3
EC 112 Ms. Leigh Gushea Vol #: 3
EC 113 Mr. James Hawes, ARNP-CRNA Vol #: 3
EC 114 AANA Vol #: 3
EC 115 Kentucky Association of Nurse Anesthetists Vol #: 3
EC 116 Mrs. Miriam Talley CRNA Vol #: 3
EC 117 Mr. Robert Hitt Vol #: 3
EC 118 Dr. howard reynolds Vol #: 3
EC 119 Member of AANA Vol #: 3
EC 120 Saint Vincent Memorial Hospital Vol #: 3
EC 121 Mr. James Neblett III Vol #: 3
EC 122 altru hospital Vol #: 3
EC 123 University Anesthesiologists, Inc Vol #: 3
EC 124 Mrs. Misty Montellano Vol #: 3
EC 125 Mrs. kim thomas Vol #: 3
EC 126 anesthesia medical group of santa cruz, inc. Vol #: 3
EC 127 Mrs. Karenn Hall Vol #: 3
EC 128 Dr. Alan Angel Vol #: 3
EC 129 Wichita Falls Endoscopy Center Vol #: 3
EC 130 Dr. Kevin Pace Vol #: 3
EC 131 Digestive Vol #: 3
EC 132 UW School of Medicine Vol #: 3
EC 133 University of Rochester Vol #: 3
EC 134 Dr. Maurizio Solca Vol #: 3
EC 135 Mr. Nick Hill Vol #: 3
EC 136 Dr. LUCIA CAPELLARO Vol #: 3
EC 137 Dr. Roger Mattison Vol #: 3
EC 138 Dr. Jonathan Radin Vol #: 3
EC 139 None Vol #: 3
EC 140 Huntsville Hospital Systems Vol #: 3
EC 141 University of Udine, Italy Vol #: 3
EC 142 UAB Medical Center Vol #: 3
EC 143 Dr. James McKenna Vol #: 3
EC 144 Dr. Lynn Mishkel Vol #: 3
EC 145 Children's Anesthesiologists, PC Vol #: 3
EC 146 Mrs. Lynn Coyne Vol #: 3
EC 147 Dartmouth Hitchcock Medical Center Vol #: 3
EC 148 Tejas Anesthesia, PA/Texas Society of Anes. Vol #: 3
EC 149 Dr. Richard Siegenfeld Vol #: 3
EC 150 Dr. james dooley Vol #: 3
EC 151 CHESHIRE MEDICAL CENTER Vol #: 3
2005P-0323 Immediately remove Adderall and Adderall XR from the market for safety reasons
EC 2 The Oaks Treatment Center Vol #: 1
2005P-0436 ADA 21-863' Ibuprogen Liquid filled gelatin capsules 200 mg; Ranbaxy Laboratories, Ltd.
ACK 1 HFA-305 to Frommer Lawrence & Haug LLP Vol #: 1
2005P-0440 To deny approval of Smith & Nephew's premarket approval application (PMA) for the Birmingham hip resurfacing system (P040033) based on the data currently submitted in support of the PMA
ACK 1 HFA-305 to Wright Medical Technology, Inc. Vol #: 1
CP 1 Wright Medical Technology, Inc. Vol #: 1

Page created on April 26, 2006 RSC

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management